Infectious Diseases (all articles) | Page 137 of 298 | Links Medicus Content Curation & Alerts in Medicine

Denmark has temporarily suspended use of the Oxford-AstraZeneca covid-19 vaccine as a precautionary move after reports of blood clots. But the EMA and the UK’s regulatory body say there is no indication that vaccination is linked to thromboembolic events https://t.co/sW8GRqcnLg

— The BMJ (@bmj_latest) March 11, 2021

Update to living systematic review on covid-19 in pregnancy

12 Mar, 2021 | 08:28h | UTC

Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis – The BMJ

News release: Update to living systematic review on covid-19 in pregnancy – The BMJ

Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies

12 Mar, 2021 | 08:23h | UTC

Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies – Nature

Perspective | Long Covid isn’t as unique as we thought

12 Mar, 2021 | 08:27h | UTC

Long Covid isn’t as unique as we thought – Vox

Perspective | Immunity to SARS-CoV-2 variants of concern

12 Mar, 2021 | 08:24h | UTC

Immunity to SARS-CoV-2 variants of concern – Science

Commentary on Twitter

https://twitter.com/EricTopol/status/1370094431668375552

CDC Interim Recommendations for Fully Vaccinated People: An Important First Step

12 Mar, 2021 | 08:22h | UTC

CDC Interim Recommendations for Fully Vaccinated People: An Important First Step – JAMA

Original Guidance and Commentaries: New CDC Guideline for fully vaccinated individuals says people can get together indoors without masks. Precautions should continue in public.

[Press release – not published yet] Monoclonal antibodies reduced hospitalizations and death in Phase 3 trial for early COVID-19

11 Mar, 2021 | 08:41h | UTC

Press release: Lilly’s bamlanivimab and etesevimab together reduced hospitalizations and death in Phase 3 trial for early COVID-19

Commentary: Eli Lilly’s combo therapy for COVID-19 cuts serious illness and death in large study – Reuters

Death rate 64% higher with B117 COVID variant, study finds

11 Mar, 2021 | 08:38h | UTC

Death rate 64% higher with B117 COVID variant, study finds – CIDRAP

News release: Variant B.1.1.7 of COVID-19 associated with a significantly higher mortality rate, research shows – University of Bristol

Original Study: Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study – The BMJ

Study from 116 countries suggests surgery should be delayed for at least seven weeks following a COVID-19 diagnosis to reduce mortality risk

11 Mar, 2021 | 08:35h | UTC

Study from 116 countries suggests surgery should be delayed for at least seven weeks following a COVID-19 diagnosis to reduce mortality risk – Association of Anaesthetists of Great Britain and Ireland

Original study: Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study – Anaesthesia

Commentary on Twitter

Reported by > 100 news organisations and > 200k Twitter impressions in just a few hours!

Here is the new @CovidSurg infographic! Time to establish timing of surgery guidelines?@aneelbhangu @dnepo @JoanaffSimoes #FOAMed

🔗https://t.co/mRnV7U6u1w pic.twitter.com/BmKlxf9ZIK

— 𝘈𝘯𝘢𝘦𝘴𝘵𝘩𝘦𝘴𝘪𝘢 (@Anaes_Journal) March 10, 2021

[Preprint] RECOVERY trial: Convalescent plasma does not improve outcomes in patients admitted to hospital with COVID-19

11 Mar, 2021 | 08:43h | UTC

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial – medRxiv

Commentary on Twitter (thread – click for more)

RECOVERY Pre-print:

Convalescent plasma does not improve survival in patients hospitalised with COVID-19 in this randomised controlled trial involving 11,558 patients:https://t.co/36YZwJNY3Q pic.twitter.com/sKR095n1PC

— Martin Landray (@MartinLandray) March 10, 2021

State of the Art Review | Severe covid-19 pneumonia: pathogenesis and clinical management

11 Mar, 2021 | 08:37h | UTC

Severe covid-19 pneumonia: pathogenesis and clinical management – The BMJ

Clinical Decisions | Doctor, How Long Should I Isolate?

11 Mar, 2021 | 08:21h | UTC

Doctor, How Long Should I Isolate? – New England Journal of Medicine

Study: Children and young people remain at low risk of COVID-19 mortality

11 Mar, 2021 | 08:28h | UTC

Children and young people remain at low risk of COVID-19 mortality – The Lancet Child and Adolescent Health

Attributes and predictors of long COVID

11 Mar, 2021 | 08:25h | UTC

Attributes and predictors of long COVID – Nature

Commentary on Twitter

https://twitter.com/ASPphysician/status/1369617507405946881

Audio Interview: The implications of changes in the structural biology of SARS-CoV-2

11 Mar, 2021 | 08:20h | UTC

Audio Interview: The Implications of Changes in the Structural Biology of SARS-CoV-2 – New England Journal of Medicine

More data suggesting a single dose of SARS-CoV-2 mRNA vaccine may be enough in seropositive individuals

11 Mar, 2021 | 08:18h | UTC

Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine – New England Journal of Medicine

Commentary: Second shot of COVID-19 vaccine may not be necessary in previously infected individuals: study – The Mount Sinai Hospital

M-A: Serological evidence of human infection with SARS-CoV-2

10 Mar, 2021 | 08:42h | UTC

Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis – The Lancet Global Health

Invited Commentary: COVID-19 serosurveys for public health decision making – The Lancet Global Health

Commentary on Twitter (thread – click for more)

Now out: our systematic review and meta-analysis on seroprevalence surveys for SARS-CoV-2 is now out @LancetGH, collaboration with Hongjie Yu and team @FudanUniv. #COVID19. A short thread: 1/n https://t.co/EHLTc9AUCq

— Daniel T Leung (@GlobalGutHealth) March 9, 2021

Lab study shows Pfizer/BioNTech COVID-19 vaccine can also neutralize B.1.351, P1 and B.1.1.7 variants

10 Mar, 2021 | 08:43h | UTC

Neutralizing Activity of BNT162b2-Elicited Serum – New England Journal of Medicine

Commentaries: Expert reaction to NEJM correspondence paper looking at the neutralising activity of the Pfizer-BioNTech vaccine against SARS-CoV-2 variants in the lab – Science Media Centre AND Pfizer/BioNTech COVID-19 vaccine neutralizes Brazil variant in lab study – Reuters

Study: Home testing for COVID-19 could prevent infections and reduce deaths at justifiable cost

10 Mar, 2021 | 08:40h | UTC

News release: Home testing for COVID-19 could prevent infections and reduce deaths at justifiable cost – Yale University

Original study: Clinical and Economic Effects of Widespread Rapid Testing to Decrease SARS-CoV-2 Transmission – Annals of Internal Medicine

Commentary on Twitter

Model-based analysis by @ADPaltiel, Amy Zheng of @YaleMed and @PaulSaxMD of @BrighamWomens.

A nationwide program of frequent home testing and self-isolation could greatly reduce total #COVID19 infections and mortality at a justifiable cost https://t.co/8AglZQXpuL. pic.twitter.com/5gQV3i0NxG

— Annals of Int Med (@AnnalsofIM) March 8, 2021